DE69131428T2 - Individuelle stereoisomere von 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone und naphthyridone als antibakterielle wirkstoffe - Google Patents

Individuelle stereoisomere von 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone und naphthyridone als antibakterielle wirkstoffe

Info

Publication number
DE69131428T2
DE69131428T2 DE69131428T DE69131428T DE69131428T2 DE 69131428 T2 DE69131428 T2 DE 69131428T2 DE 69131428 T DE69131428 T DE 69131428T DE 69131428 T DE69131428 T DE 69131428T DE 69131428 T2 DE69131428 T2 DE 69131428T2
Authority
DE
Germany
Prior art keywords
aminoalkyl
naphthyridone
quinolone
pyrrolidinyl
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131428T
Other languages
English (en)
Other versions
DE69131428D1 (de
Inventor
John DOMAGALA
John Kiely
Mel Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE69131428D1 publication Critical patent/DE69131428D1/de
Application granted granted Critical
Publication of DE69131428T2 publication Critical patent/DE69131428T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
DE69131428T 1990-11-30 1991-11-12 Individuelle stereoisomere von 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone und naphthyridone als antibakterielle wirkstoffe Expired - Fee Related DE69131428T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62120190A 1990-11-30 1990-11-30
US73182591A 1991-07-15 1991-07-15
PCT/US1991/008419 WO1992009596A1 (en) 1990-11-30 1991-11-12 Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents

Publications (2)

Publication Number Publication Date
DE69131428D1 DE69131428D1 (de) 1999-08-12
DE69131428T2 true DE69131428T2 (de) 2000-01-05

Family

ID=27088892

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131428T Expired - Fee Related DE69131428T2 (de) 1990-11-30 1991-11-12 Individuelle stereoisomere von 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone und naphthyridone als antibakterielle wirkstoffe

Country Status (14)

Country Link
EP (2) EP0909759A3 (de)
JP (1) JPH06503565A (de)
AT (1) ATE181915T1 (de)
AU (2) AU658384B2 (de)
CA (1) CA2095338C (de)
DE (1) DE69131428T2 (de)
DK (1) DK0559774T3 (de)
ES (1) ES2137942T3 (de)
GR (1) GR3031224T3 (de)
IE (1) IE62205B1 (de)
MX (1) MX9102290A (de)
NZ (1) NZ240784A (de)
PT (1) PT99657B (de)
WO (1) WO1992009596A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649893B1 (en) * 1991-11-25 1994-06-02 Warner-Lambert Company Antibacterial agents
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
AU716479B2 (en) * 1993-05-06 2000-02-24 Pharmacia & Upjohn Company Optically active 3-(1-(alkylamino) alkyl pyrrolidines
US6140510A (en) * 1993-05-06 2000-10-31 Pharmacia & Upjohn Company Optically active 3-(1-(carbamoyl))alkyl-2-oxo-pyrrolidines and optically active 3-(1-(alkylamido))alkyl-2-oxo-pyrrolidines
CA2160124A1 (en) * 1993-05-06 1994-11-24 William W. Mcwhorter Optically active 3-(1-(alkylamino)) alkyl pyrrolidines
AU709057B2 (en) * 1994-11-18 1999-08-19 Pharmacia & Upjohn Company A new physically stable solid form of a fluoroquinolone
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
ES2188940T3 (es) * 1996-05-10 2003-07-01 Upjohn Co Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas.
KR100395779B1 (ko) * 2001-05-25 2003-08-21 한국화학연구원 임의적으로 베타-위치가 치환된 알파-아릴알킬기의 제거를통해 3급 아미드 화합물로부터 2급 아미드 화합물을제조하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
US5157128A (en) * 1990-11-30 1992-10-20 Warner-Lambert Company Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체

Also Published As

Publication number Publication date
CA2095338C (en) 2002-04-09
WO1992009596A1 (en) 1992-06-11
AU678715B2 (en) 1997-06-05
CA2095338A1 (en) 1992-05-31
DE69131428D1 (de) 1999-08-12
AU2334495A (en) 1995-09-07
EP0909759A3 (de) 2000-04-26
DK0559774T3 (da) 2000-01-31
PT99657B (pt) 1999-05-31
GR3031224T3 (en) 1999-12-31
MX9102290A (es) 1992-07-08
NZ240784A (en) 1997-06-24
EP0559774A1 (de) 1993-09-15
IE914160A1 (en) 1992-06-03
JPH06503565A (ja) 1994-04-21
EP0909759A2 (de) 1999-04-21
EP0559774B1 (de) 1999-07-07
ES2137942T3 (es) 2000-01-01
AU9057491A (en) 1992-06-25
AU658384B2 (en) 1995-04-13
ATE181915T1 (de) 1999-07-15
PT99657A (pt) 1992-12-31
IE62205B1 (en) 1994-12-28

Similar Documents

Publication Publication Date Title
NZ227680A (en) Quinoline and naphthyridine derivatives, intermediates and pharmaceutical compositions
NO873125D0 (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
DE69131428D1 (de) Individuelle stereoisomere von 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolone und naphthyridone als antibakterielle wirkstoffe
EP0235589A3 (en) Use of quinolone and naphthyridine antibiotics for the manufacture of ophthalmic medicaments
NO901008D0 (no) Fremgangsmaate for fremstilling av (3-(c16-c18)alkansulfinyl- og sulfonyl-2-methoxymethyl-propyl)-(2-trimethylaminio-ethyl)-fosfater.
DK0393424T3 (da) Fremgangsmåde til fremstilling af 2,7-diazabicyclo(3.3.0)octaner
DE69128838T2 (de) Optische isomere von 7-[3-(1-dialkylmethyl-1-amino)-1-pyrolidinyl]-chinolone und napthyridone als antibakterielle wirkstoffe
ES2056381T3 (es) Preparacion de intermedios diazabiciclos.
ATE176477T1 (de) Neue phospholipidderivate
ZA919458B (en) Individual stereoisomers of 7-[3-(aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee